Nina Kumowski Katharina Sch tt Abstract Diabetes is a very important comorbidity in patients with heart failure When both diseases coexist cardiovascular morbidity and mortality is greatly increased Therefore it is of clinical importance to treat both diseases as early as possible with an optimal therapy Hitherto heart failure therapy did not differ if a patient had concomitant diabetes However with SGLT inhibitors having demonstrated to reduce hospitalization of heart failure independent of diabetes state and expected to be included into the ESC heart failure treatment guidelines in coexisting diabetes potentially will make a difference when to start therapy In this article we provide an overview of current recommendations and also provide clinical considerations for the therapy of heart failure with concomitant diabetes Sources 